Loading, please wait...
 |
P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCPS; Associate Professor and Director of Residency & Fellowship Training, University of South Carolina College of Pharmacy; Infectious Diseases PGY2 and Clinical Fellowship Director, USC/Prisma Health Richland
|
Navigating Pneumococcal Immunization Recommendations, Module 1: Understanding CDC/ACIP Updates and Rationales
(Tuesday March 2, 8:00-9:00pm EST)
|
 |
Julie Sease, PharmD, FCCP, BCPS, CDCES, BCACP;
Senior Associate Dean and Professor, University of South Carolina College of Pharmacy
|
Navigating Pneumococcal Immunization Recommendations, Module 2: Optimizing Pharmacist-Led Identification of High-Risk Patients Aged 19 to 64
(Thursday March 4, 8:00-9:00pm EST)
|
  |
Tessa Hastings, PhD; Assistant Professor, University of South Carolina College of Pharmacy
Kathy Quarles Moore, B.S.Pharm, RPh, CDM;
Lab Director: Community & Compounding Labs; Clinical Assistant Professor, University of South Carolina College of Pharmacy
|
Navigating Pneumococcal Immunization Recommendations, Module 3: Bringing Down the Barriers to Vaccinations Provided in a Pharmacy Setting
(Tuesday March 9, 8:00-9:00pm EST)
|
  |
Betsy Blake, PharmD, BCPS; Director of Interprofessional Education and Clinical Associate Professor, University of South Carolina College of Pharmacy; Co-Chair, Interprofessional Education for the Health Sciences, University of South Carolina
Patricia H. Fabel, PharmD, BCPS; Executive Director, Kennedy Pharmacy Innovation Center; Clinical Associate Professor, University of South Carolina College of Pharmacy
|
Navigating Pneumococcal Immunization Recommendations, Module 4: Creating a Strategy for Pharmacist-Led Shared Decision-Making in Patients 65 and Older
(Thursday March 11, 8:00-9:00pm EST)
|
Date: Mar 2, 2021 08:00 PM - Mar 11, 2021 09:00 PM
Fee
CE Hours
CE Units
Registration closes on Mar 02, 2021 07:00 PM
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
Accreditation(s)
|
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Registration closes on Mar 02, 2021
at 07:00 PM
Registration Closed
- Describe the causative agent, associated diseases, and patients at highest risk of invasive pneumococcal disease
- Describe pneumococcal vaccine characteristics including schedule of administration, contraindications, and common adverse reactions
- Discuss historical and current pneumococcal vaccine recommendations for adults
Speaker(s)/Author(s)
|
P. Brandon Bookstaver, PharmD, FCCP, BCIDP
|
Activity Number
0062-0000-21-032-L06-PCE Hours
Registration closes on Mar 02, 2021
at 07:00 PM
Registration Closed
- Relate key conditions to the qualification of a patient for pneumonia vaccination between the ages of 19 and 64
- Utilize resources such as PneumoRecs VaxAdvisor to correctly identify patients at high-risk who qualify for pneumonia vaccination between the ages of 19 and 64
- Select appropriate pneumonia vaccination regimens for patients who qualify and are between the ages of 19 and 64
Speaker(s)/Author(s)
|
Julie Sease, PharmD, FCCP, BCPS, CDCES, BCACP
|
Activity Number
0062-0000-21-033-L06-PCE Hours
Registration closes on Mar 02, 2021
at 07:00 PM
Registration Closed
- Identify barriers specific to the provision of vaccinations in a pharmacy setting
- Recognize patient-related barriers to acceptance of pneumococcal vaccination
- Determine communication strategies to overcome vaccine hesitancy
Speaker(s)/Author(s)
|
Kathy Quarles-Moore, B.S.Pharm, RPh, CDM
|
|
|
Tessa Hastings, PhD
|
Activity Number
0062-0000-21-034-L06-PCE Hours
Registration closes on Mar 02, 2021
at 07:00 PM
Registration Closed
- Describe the concept of shared clinical decision making and how it is incorporated into therapeutic decisions regarding vaccines
- Utilize available resources and evidence-based literature to determine ideal candidates to receive the pneumococcal conjugate 13-valent vaccine after the age of 65
- Demonstrate appropriate communication strategies given a patient-specific scenario to utilize shared clinical decision making to discuss recommendations for the pneumococcal conjugate 13-valent vaccine
Speaker(s)/Author(s)
|
Betsy Blake, PharmD, BCPS, FNAP
|
|
|
Patricia Fabel, PharmD, BCPS
|